Deep Informatics (迪英加)

Hangzhou, China

Deep Informatics is a tumor biopsy and artificial intelligence platform, dedicated to the use of artificial intelligence for medical imaging assistance diagnosis. The current products include Deep Informatic's cloud platform and the world's leading database, based on the depth of learning digital pathological slices artificial intelligence analysis and diagnosis, to achieve quantitative analysis of cancer, reduce reading costs and improve diagnostic accuracy for the hospital to provide digital pathology remote Reading and consultation of a full set of digital pathology solutions.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Deep Informatics (迪英加) on @MedStartr Today #Tumors #CancerDiagnosis #CancerOncology #AIML #Cancer #Diagnostics #Informatics #MedMo #MedStartrVentures

https://www.medstartr.ai/s/eaGCFS4Buyw

Get Involved in Deep Informatics (迪英加)

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2017
Website: www.deepinformatics.com.cn

Disease Areas

Tumors Cancer Diagnosis Cancer & Oncology

Technologies

Digital PathologyMedical Image AnalysisDeep Learning

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Deep Informatics (迪英加)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.